Literature DB >> 12025885

Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation.

U Andersson1, K Grankvist, A T Bergenheim, P Behnam-Motlagh, H Hedman, R Henriksson.   

Abstract

The influence of radiotherapy on malignant glioma multidrug resistance to chemotherapy was evaluated because patients with glioma often are treated with a combination of radiotherapy and chemotherapy. Multidrug resistance gene (MDR1, mdr1a, and mdr1b) transcripts were found in human and rat glioma cell lines. P-Glycoprotein (Pgp) was immunohistochemically detected in glioma cell lines and in the rat brain vascular endothelial cell line (RBE4). A multidrug resistance pump efflux activity assay demonstrated increased calcein efflux of RBE4 endothelial cells, but not glioma cells, 2 h after irradiation and still increased 14 d after irradiation. The increased efflux was equally inhibited by verapamil with or without irradiation. In the rat intracranial glioma model (BT4C), Pgp was demonstrated in capillary endothelial cells of the tumor tissue and surrounding normal brain, but not in tumor cells. The expression of gene transcripts or Pgp was not affected by irradiation. The results indicate that long-lasting verapamil-resistant drug efflux mechanisms are activated in brain endothelial cells after irradiation. The results might explain the poor efficacy of chemotherapy following radiotherapy and contribute to consideration of new treatment strategies in the management of malignant glioma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12025885     DOI: 10.1385/MO:19:1:1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  31 in total

Review 1.  The physiological function of drug-transporting P-glycoproteins.

Authors:  A H Schinkel
Journal:  Semin Cancer Biol       Date:  1997-06       Impact factor: 15.707

2.  Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis.

Authors:  M Arboix; O G Paz; T Colombo; M D'Incalci
Journal:  J Pharmacol Exp Ther       Date:  1997-06       Impact factor: 4.030

3.  Radiation therapy of 9L rat brain tumors.

Authors:  S D Henderson; B F Kimler; R A Morantz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-04       Impact factor: 7.038

4.  Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance.

Authors:  J D Allen; R F Brinkhuis; L van Deemter; J Wijnholds; A H Schinkel
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

5.  Expression of P-glycoprotein, a multidrug-resistance gene product, is induced by radiotherapy in patients with oral squamous cell carcinoma.

Authors:  I O Ng; K Y Lam; M Ng; D L Kwong; J S Sham
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

6.  Enhanced expression of neuropeptides in human breast cancer cell lines following irradiation.

Authors:  Y Aalto; S Forsgren; U Kjörell; J Bergh; L Franzén; R Henriksson
Journal:  Peptides       Date:  1998       Impact factor: 3.750

7.  Permeability characteristics of brain adjacent to tumors in rats.

Authors:  V A Levin; M Freeman-Dove; H D Landahl
Journal:  Arch Neurol       Date:  1975-12

Review 8.  Genetic aspects of multidrug resistance.

Authors:  J L Biedler
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

9.  Microfluorometric evaluation of calcein acetoxymethyl ester as a probe for P-glycoprotein-mediated resistance: effects of cyclosporin A and its nonimmunosuppressive analogue SDZ PSC 833.

Authors:  G Liminga; P Nygren; R Larsson
Journal:  Exp Cell Res       Date:  1994-06       Impact factor: 3.905

10.  Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts.

Authors:  Y Takamiya; Y Abe; Y Tanaka; A Tsugu; M Kazuno; Y Oshika; K Maruo; Y Ohnishi; O Sato; H Yamazaki; H Kijima; Y Ueyama; N Tamaoki; M Nakamura
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  4 in total

Review 1.  Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions.

Authors:  Françoise Roux; Pierre-Olivier Couraud
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 2.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.

Authors:  Rolf F Barth; Balveen Kaur
Journal:  J Neurooncol       Date:  2009-04-21       Impact factor: 4.130

Review 3.  Pharmacotherapy for adults with tumors of the central nervous system.

Authors:  Nina F Schor
Journal:  Pharmacol Ther       Date:  2008-11-27       Impact factor: 12.310

Review 4.  Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance.

Authors:  Md Mominur Rhaman; Md Rezaul Islam; Shopnil Akash; Mobasharah Mim; Md Noor Alam; Eugenie Nepovimova; Martin Valis; Kamil Kuca; Rohit Sharma
Journal:  Front Cell Dev Biol       Date:  2022-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.